XM does not provide services to residents of the United States of America.

U.S. stocks weekly: Rocky



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. stocks weekly: Rocky</title></head><body>

** S&P 500 .SPX falls second straight week, loses 0.8% in choppy trading .N

** Nasdaq composite .IXIC internal measure hits hurdle, and 50-day moving average may be a magnet; IXIC loses 2.1%

** Small-cap Russell 2000 .RUT: More thrust, or bust?; RUT advances 3.5%

** Though, by Fri, after sharp slide, SPX seeks to stabilize

** In the end, just a minority of sectors rattled; Communication Services most unsteady, while defensive plays and Healthcare are ballasts

** Communication Services .SPLRCL dive 3.8%. Google parent Alphabet GOOGL.O falls as rising AI capex overshadows Q2 beat, and drops after Microsoft-backed MSFT.O OpenAI tests SearchGPT online search tool

Warner Bros Discovery WBD.O declines after failing to renew NBA broadcasting rights

** Tech .SPLRCT retreats 2.4%. U.S. chip stocks extend selloff after disappointing earnings from firms across the globe, and on AI rally sustainability jitters

Semiconductor index .SOX sags ~3%

But IBM IBM.N climbs after rev beat, software business forecast boost

** Consumer Discretionary .SPLRCD falls 2.3%. Ford F.N skids 20% after Q2 profit miss as quality issues linger. Tesla TSLA.O slumps as profit margins drop to over five-yr lows

** Industrials .SPLRCI gain 1.1%. 3M MMM.N soars as strong results highlight cost cuts, growth push. Though UPS UPS.N falls after Q2 results miss as cheap deliveries weigh on earnings

** S&P Financials .SPSY up 1.3%. MSCI MSCI.N among top sector gainers, rallies 9% after Q2 profit rises on robust demand

S&P 500 banks index .SPXBK up ~1%; KBW regional banking index .KRX advances 5.4%

** Healthcare .SPXHC rises 1.4%. Insurer Molina Healthcare MOH.N jumps after Q2 beat on higher premiums from Medicaid plans

In contrast, Dexcom DXCM.O plunges as glucose monitor maker's rev forecast cut spooks investors. DXCM dives 43% on the week

** Meanwhile, individual investor bulls tumble, bears jump

** SPX performance YTD:



Tech

23.4%

Comm Svcs

18.1%

Financials

15.2%

SPX

14.5%

Utils

12.3%

Industrials

10.8%

Staples

10.3%

Energy

10.1%

Healthcare

9.8%

Materials

6.7%

Discretionary

4.2%

Real Estate

1.6%



(Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.